Bio-Rad Laboratories | BIO - Current Assets


Bio-Rad Laboratories reported $2.84B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 24.84B 371M Sep/2025
Agilent USD 4.59B 341M Sep/2025
Becton, Dickinson and Co. USD 9.26B 258M Sep/2025
Bio Techne USD 609.51M 1.21M Sep/2025
Bio-Rad Laboratories USD 2.84B 30.9M Sep/2025
Bruker USD 2.35B 187.9M Sep/2025
Charles River Laboratories USD 1.53B 62.24M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Exact Sciences USD 1.59B 82.87M Sep/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Hologic USD 3.84B 175.3M Dec/2025
Illumina USD 2.8B 155M Sep/2025
IQVIA Holdings USD 5.98B 366M Sep/2025
Laboratory Of America USD 4.08B 8.4M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Mettler Toledo International USD 1.28B 36.74M Sep/2025
Myriad Genetics USD 344.8M 60.5M Sep/2025
Quest Diagnostics USD 2.41B 209M Sep/2025
Repligen USD 1.1B 39.62M Sep/2025
Revvity USD 2.14B 92.4M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 64.71B 1.08B Sep/2025
Standard Biotools USD 472.44M 33.6M Sep/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Tosoh JPY 731.01B 3.35B Sep/2025
Waters USD 1.92B 137.07M Sep/2025